For more than two decades, biopharma has struggled to develop safe and effective non-opioid pain therapies. With Vertex’s recent approval marking a long-awaited breakthrough, the momentum has reached a critical point for bringing non-opioid pain therapeutics to market.

Time: 9:00 AM – 3:00 PM

Venue details: The Colonnade Hotel, 120 Huntington Avenue, Boston, Massachusetts, 02116, United States

Prices: USD 2199.00 – USD 5097.00

Speakers: Michele Curatolo, Chief Medical Officer and Professor of Anesthesiology and Pain Medicine, 4E Therapeutics and University of Washington, and more